Cart
sales@molnova.com
Gardenin B
CAS No. 2798-20-1
Gardenin B( —— )
Catalog No. M24193 CAS No. 2798-20-1
Gardenin B exhibits superior antiproliferative activity against lung, breast, colon, hepatic and leukaemia cell lines as well as in keratinocytes .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 144 | In Stock |
|
| 10MG | 212 | In Stock |
|
| 25MG | 356 | In Stock |
|
| 50MG | 528 | In Stock |
|
| 100MG | 755 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGardenin B
-
NoteResearch use only, not for human use.
-
Brief DescriptionGardenin B exhibits superior antiproliferative activity against lung, breast, colon, hepatic and leukaemia cell lines as well as in keratinocytes .
-
DescriptionGardenin B exhibits superior antiproliferative activity against lung, breast, colon, hepatic and leukaemia cell lines as well as in keratinocytes .
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetCaspase
-
RecptorCaspase|NO Synthase|ROS
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2798-20-1
-
Formula Weight358.4
-
Molecular FormulaC19H18O7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 10 mg/mL (27.91 mM)
-
SMILESCOc(cc1)ccc1C(Oc(c(OC)c1OC)c2c(O)c1OC)=CC2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gardenin B-induced cell death in human leukemia cells involves multiple caspases but is independent of the generation of reactive oxygen species.Chem Biol Interact. 2016 Aug 25;256:220-7.
molnova catalog
related products
-
Raptinal
Raptinal activates caspase-3 directly and initiates intrinsic caspase-dependent apoptosis pathway in multiple cell lines.
-
Ac-DEVD-AMC
Ac-DEVD-AMC is the substrate of Caspase-3 .
-
Procaspase-3 activat...
Procaspase-3 activator 1541B is a specific, small molecule activator of procaspases-3 with EC50 of 1.3 uM.
